88 results
8-K
ACUR
Acura Pharmaceuticals, Inc
26 May 23
Entry into a Material Definitive Agreement
8:30am
such amount is paid in full.
The funding provided by AD Pharma, along with the $235,000 received in May 2023 under the employee retention credit (“ERC
S-8
ACUR
Acura Pharmaceuticals, Inc
1 Jun 21
Registration of securities for employees
4:10pm
to a $1,000,000 retention for securities claims, $1,000,000 for claims arising out of merger and acquisition activity, and $1,000,000 for all other claims